← Back to patent-cliff list
CAS 2102429-29-6
3-(N'-Hydroxycarbamimidoyl)-1-oxidopyridin-1-ium
Codes: (I)320339-4-a
Application context (from source-drug indications)
C型尼曼匹克病Arimoclomol Citrate包涵体肌炎Arimoclomol CitrateIII 型戈谢病Arimoclomol CitrateI 型戈谢病Arimoclomol CitrateAmyotrophic lateral sclerosisArimoclomol Citrate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Arimoclomol Citrate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
3-(N'-Hydroxycarbamimidoyl)-1-oxidopyridin-1-ium→2-Hydroxy-4-azaspiro[3.5]nonan-4-ylium chloride→3-{N'-[2-Hydroxy-3-(piperidin-1-yl)propoxy]carbamimidoyl}-1-oxidopyridin-1-ium→3-[1-Chloro-1-[2-hydroxy-3-(1-piperidinyl)propoxyiminomethyl]pyridine 1-oxide→(2R,3R)-2,3-Bis(benzoyloxy)butanedioic acid N-[(2R)-2-hydroxy-3-(piperidin-1-yl)propoxy]-1-oxo-1lambda5-pyridine-3-carboximidoyl chloride→N-[(2R)-2-Hydroxy-3-(piperidin-1-yl)propoxy]-1-oxo-1lambda5-pyridine-3-carboximidoyl chloride
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.